AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

PLERIXAFOR

7 registrations across 3 African markets— 5 active

Markets with PLERIXAFOR

🇿🇦South Africa
4 registrations
3 active
🇺🇬Uganda
2 registrations
2 active
🇹🇳Tunisia
1 registration
0 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
XAFTRID🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveOct 2027
PLEDITEX🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveOct 2027
ZAPLEXET🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveOct 2027
MOZOBIL🇿🇦South AfricaSanofi-Aventis South Africa (Pty) LtdsuspendedMay 2025
PLERIXAFOR NEAPOLIS
Solution injectable / 20 mg/ml
🇹🇳TunisiaNEAPOLIS PHARMAexpiredJul 2023
PLERIXAFOR
PARENTERAL ORDINARY VIALS
🇺🇬UgandaAUROBINDO PHARMA LIMITEDactive—
PLERIXAFOR
PARENTERAL ORDINARY VIALS
🇺🇬UgandaAUROBINDO PHARMA LIMITEDactive—

PLERIXAFOR in Africa — Regulatory Overview

PLERIXAFOR is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Uganda, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.

Of the 7 registrations, 5 (71%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.